Presented by expert speakers, our workshops will give you advance insight into topics that will be covered at the event.

Can’t make the date? Still register to receive the workshop recording afterwards.

Pharma IT & Data Digital Workshop

Fair Data & Analytics

Wednesday 8th July 2020 | 15:00 - 17:30 PM BST

Presentation 1 | 15:00 – 15:30 PM : Implementing FAIR Data At Teva: Case Studies
hosted by Lena Granovsky, Senior Director, Head of Analytics & Big Data, Teva

Presentation 2 | 15:30 – 16:00 PM : Sage: A FAIR Data Platform for Pharma R&D 
hosted by Ajay Shah, Executive Director and Head of IT for Translational Medicine, Bristol-Myers Squibb

Presentation 3 | 16:00 – 16:30 PM : Towards Analytical Reasoning With FAIR Data
hosted by Edwin Trautman, Vice President, Science, Clinical Analyticsand Informatics, Pfizer

Presentation 4 | 16:30 – 17:00 PM : Strategies For Alternative Data Collection Mechanisms
hosted by Victoria Gamerman, Head of US Health Informatics & Analytics, Boehringer Ingelheim

Presentation 5 | 17:00 – 17:30 PM : Integration Of RESTful API Data Sources With Visualization Platforms (Spotfire Use Case)
hosted by Dunja Petrovic, Scientific Data Analyst, MSD

  • Lena Granovsky, Senior Director, Head of Analytics & Big Data, Teva
  • Ajay Shah, Executive Director and Head of IT for Translational Medicine, Bristol-Myers Squibb
  • Edwin Trautman, Vice President, Science, Clinical Analyticsand Informatics, Pfizer
  • Victoria Gamerman, Head of US Health Informatics & Analytics, Boehringer Ingelheim
  • Dunja Petrovic, Scientific Data Analyst, MSD

AI in Drug Development Webinar:

The Use Of BenevolentAI’s Platform To Identify And Validate Novel Targets For Neurological Diseases

Wednesday 13th May 2020 | 2pm UK time

Presented by Jackie Hunter, CE, Clinical and Strategic Partnerships, BenevolentAI

  • This webinar will showcase BenevolentAI’s platform and describe how it can be used in different ways along the drug discovery and development process
  • Specific examples will be described in the identification of novel targets for neurological diseases for which there are currently no good treatment options

Professor Jackie Hunter held senior positions at global pharmaceutical organisations including GSK, Proximagen and OI Pharma Partners before joining BenevolentAI as a Director in 2016. She brings vast academic and business experience in the biomedical and pharmaceutical sectors. She directs the application of BenevolentAI’s technology for clinical development and gives the company the insight it needs to operate its unique business model – one which sees it not only researching, but also developing the blueprint for new drugs.

Smartlabs & Laboratory Informatics Digital Workshop

Towards The Lab Of The Future​

Friday 3rd July 2020 | 14:00 - 16:00 PM BST

Presentation 1 | 14:00 – 14:30 PM : Computational Biology In The Future Lab
Hosted by Anthony Rowe, Senior Director, Head – Discovery, Product Development & Supply IT, Janssen

Presentation 2 | 14:30 – 15:00 PM : Global Lab Infrastructure At Roche
Hosted by Alexander Rossi, Head Laboratory Informatics – Systems & Services, Roche

Presentation 3 | 15:00 – 15:30 PM : Pistoia Alliance Lab Of The Future Strategy: Building The LotF On Solid Foundations
Hosted by Gerhard Noelken, Lab of the Future Project Lead, Pistoia Alliance

Presentation 4 | 15:30 – 16:00 PM : User Experience In Research Informatics
Hosted by Jacek Ziemski, IT Expert / UX & Product Design, Roche

  • Anthony Rowe, Senior Director, Head – Discovery, Product Development & Supply IT, Janssen
  • Alexander Rossi, Head Laboratory Informatics – Systems & Services, Roche
  • Gerhard Noelken, Lab of the Future Project Lead, Pistoia Alliance
  • Jacek Ziemski, IT Expert / UX & Product Design, Roche

AI in Drug Development Webinar:

The Use Of BenevolentAI’s Platform To Identify And Validate Novel Targets For Neurological Diseases

Wednesday 13th May 2020 | 2pm UK time

Presented by Jackie Hunter, CE, Clinical and Strategic Partnerships, BenevolentAI

  • This webinar will showcase BenevolentAI’s platform and describe how it can be used in different ways along the drug discovery and development process
  • Specific examples will be described in the identification of novel targets for neurological diseases for which there are currently no good treatment options

Professor Jackie Hunter held senior positions at global pharmaceutical organisations including GSK, Proximagen and OI Pharma Partners before joining BenevolentAI as a Director in 2016. She brings vast academic and business experience in the biomedical and pharmaceutical sectors. She directs the application of BenevolentAI’s technology for clinical development and gives the company the insight it needs to operate its unique business model – one which sees it not only researching, but also developing the blueprint for new drugs.

Looking for more?

All of our past webinars are available for download from our Content HUB, as well as Market Industry Reports, Q&A Sessions, Newsletters and much more.